Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   ACTAVIS
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
ACTAVIS
Dec-18
GSK PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,68416,126-   
Low Rs1,23110,818-   
Sales per share (Unadj.) Rs191.93,955.8-  
Earnings per share (Unadj.) Rs35.9-1,274.2-  
Cash flow per share (Unadj.) Rs39.8416.9-  
Dividends per share (Unadj.) Rs32.000-  
Avg Dividend yield %2.20-  
Book value per share (Unadj.) Rs102.916,315.7-  
Shares outstanding (eoy) m169.41332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.63.4 222.9%   
Avg P/E ratio x40.6-10.6 -384.2%  
P/CF ratio (eoy) x36.732.3 113.4%  
Price / Book Value ratio x14.20.8 1,715.3%  
Dividend payout %89.20-   
Avg Mkt Cap Rs m246,8584,480,758 5.5%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m5,9500-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m32,5171,315,689 2.5%  
Other income Rs m1,00725,160 4.0%   
Total revenues Rs m33,5241,340,849 2.5%   
Gross profit Rs m8,03334,478 23.3%  
Depreciation Rs m658562,428 0.1%   
Interest Rs m1875,923 0.0%   
Profit before tax Rs m8,364-578,713 -1.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m2,288-7,334 -31.2%   
Profit after tax Rs m6,076-423,784 -1.4%  
Gross profit margin %24.72.6 942.7%  
Effective tax rate %27.41.3 2,158.2%   
Net profit margin %18.7-32.2 -58.0%  
BALANCE SHEET DATA
Current assets Rs m24,943539,627 4.6%   
Current liabilities Rs m13,264477,372 2.8%   
Net working cap to sales %35.94.7 759.0%  
Current ratio x1.91.1 166.4%  
Inventory Days Days9720 496.8%  
Debtors Days Days21666 325.7%  
Net fixed assets Rs m6,988148,929 4.7%   
Share capital Rs m1,6940-   
"Free" reserves Rs m15,7350-   
Net worth Rs m17,4305,426,601 0.3%   
Long term debt Rs m01,910,903 0.0%   
Total assets Rs m31,9308,483,012 0.4%  
Interest coverage x462.6-6.6 -6,985.2%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.00.2 656.6%   
Return on assets %19.1-4.1 -465.5%  
Return on equity %34.9-7.8 -446.4%  
Return on capital %48.1-4.8 -993.5%  
Exports to sales %00-   
Imports to sales %48.10-   
Net fx Rs m-14,0080-   
CASH FLOW
From Operations Rs m4,842470,046 1.0%  
From Investments Rs m8,079258,229 3.1%  
From Financial Activity Rs m-15,433-806,740 1.9%  
Net Cashflow Rs m-2,512-78,073 3.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare GSK PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: SOTAC PHARMACEUTICALS LTD.  ORTIN LABS   JUBILANT PHARMOVA   ROOPA INDUSTRIES  VIMTA LABS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.